MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)
ImmunityBio-logo-inverted-svg-svg
ImmunityBio, Inc. (IBRX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Free Cash flow
-$70,010K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from equity offerings, ...
Change in fair value of related-...
Change in fair value of warrant ...
Others
Negative Cash Flow Breakdown
Purchases of marketable debt sec...
Accounts receivable
Purchases of property, plant and...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-230,390
-632,797
-61,958
-67,274
Change in fair value of warrant liabilities
44,190
295,413
-30,743
-14,905
Change in fair value of related-party convertible note
-95,964
-236,625
-191
-1,169
Non-cash interest expense related to revenue interest liability
11,281
8,317
8,634
9,310
Stock-based compensation expense
8,518
8,169
8,746
8,878
Depreciation and amortization
4,407
4,380
3,865
3,951
Write-off of convertible note receivable
0
7,442
-
-
Accretion of discounts on marketable debt securities, available-for-sale
2,272
1,526
1,704
978
Non-cash lease expense related to operating lease right-of-use assets-Nonrelated Party
998
956
842
830
Non-cash lease expense related to operating lease right-of-use assets-Related Party
765
741
720
698
Loss on equity method investment
-
-
14,018
-
Realized gain on instrument-specific credit risk
0
1,425
-
-
Change in fair value of derivative liabilities
692
-1,108
1,400
-289
Non-cash interest items, net
0
62
63
63
Amortization of related-party notes discounts
-
-
0
0
Unrealized losses on equity securities
-
-
0
1
Impairment of intangible assets
-
-
0
-
Transaction costs allocated to warrant liabilities
0
-
0
2,063
Other
-234
16
82
35
Accounts receivable
10,201
700
10,555
9,890
Inventories
-1,014
4,985
7,894
63
Prepaid expenses and other current assets-Nonrelated Party
-866
-1,861
-2,335
5,578
Prepaid expenses and other current assets-Related Party
-723
1,302
-727
-738
Other assets
-336
1,052
16
324
Accounts payable
-247
3,901
979
-1,392
Accrued expenses and other liabilities
8,563
3,137
1,925
5,469
Due to and due from related parties, net
595
570
-68
501
Operating lease liabilities-Nonrelated Party
-1,084
-992
-929
-912
Operating lease liabilities-Related Party
-978
-938
-912
-881
Net cash used in operating activities
-66,494
-75,359
-70,378
-68,907
Purchases of marketable debt securities, available-for-sale
164,216
139,093
45,626
180,586
Proceeds from maturities of marketable debt securities, available-for-sale
40,300
79,382
59,547
0
Proceeds from sales of marketable debt securities, available-for-sale
19,986
39,848
30,927
0
Acquisition of a business, net of transaction costs
-
-
0
0
Cash paid for other equity securities
0
10,000
0
0
Purchases of property, plant and equipment
3,516
1,776
903
741
Software development costs
23
11
372
34
Proceeds from exercise of oberland stock option, net of commissions-Stock Purchase And Option Agreement
-
-
0
0
Net cash used in investing activities
-107,469
-31,650
43,573
-181,361
Proceeds from equity offerings, net of issuance costs
-
102,227
0
-
Proceeds from equity offerings, net of issuance costs-Private Placement And At The Market Offerings
147,275
-
53,744
173,682
Proceeds from the ripa, net of issuance costs
-54
75,000
0
0
Proceeds from exercises of warrants
0
53,542
0
0
Net share settlement for rsus vesting
319
6,994
590
151
Proceeds from exercise of oberland stock option, net of commissions
-
971
-
-
Principal payments on premium financing
886
868
1,132
-
Proceeds from exercises of stock options-Options Excluding Stock Purchase And Option Agreement
1,637
-
220
-
Proceeds from exercises of stock options-Exercise Of Stock Options
-
-
-
0
Proceeds from borrowings
0
61
2,884
-
Proceeds from equity offerings, net of discounts and issuance costs-Stock Purchase And Option Agreement
-
-
0
-
Principal payments of finance leases
12
13
12
12
Net cash provided by financing activities
44,443
223,926
54,894
173,519
Effect of exchange rate changes on cash and cash equivalents, and restricted cash
-3
122
5
-56
Net change in cash and cash equivalents, and restricted cash
-129,523
117,039
28,094
-76,805
Cash and cash equivalents, and restricted cash, beginning of period
206,470
89,431
61,144
61,144
Cash and cash equivalents, and restricted cash, end of period
76,947
206,470
89,431
61,337
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
IBRX Cash Flow Sankey Diagram
Sankey diagram visualizing IBRX cash flow for the period
Proceeds from equity
offerings, net of issuance...
$147,275K
(-14.94%↓ Y/Y)
Proceeds from exercises
of stock...
$1,637K
Net cash provided by
financing activities
$44,443K
(-74.28%↓ Y/Y)
Canceled cashflow
$104,469K
Net change in cash
and cash...
-$129,523K
(-268.22%↓ Y/Y)
Canceled cashflow
$44,443K
Proceeds from maturities
of marketable debt...
$40,300K
Proceeds from sales of
marketable debt...
$19,986K
Change in fair value of
related-party convertible...
-$95,964K
(-8309.07%↓ Y/Y)
Change in fair value of
warrant liabilities
$44,190K
(1236.28%↑ Y/Y)
Non-cash interest
expense related to...
$11,281K
(12.60%↑ Y/Y)
Accrued expenses and
other liabilities
$8,563K
(-1.83%↓ Y/Y)
Stock-based compensation
expense
$8,518K
(-11.71%↓ Y/Y)
Depreciation and
amortization
$4,407K
(13.58%↑ Y/Y)
Inventories
-$1,014K
(43.79%↑ Y/Y)
Non-cash lease expense
related to operating...
$998K
(10.28%↑ Y/Y)
Prepaid expenses and
other current...
-$866K
(-121.99%↓ Y/Y)
Non-cash lease expense
related to operating...
$765K
(12.83%↑ Y/Y)
Prepaid expenses and
other current...
-$723K
(-452.68%↓ Y/Y)
Change in fair value of
derivative liabilities
$692K
(135.84%↑ Y/Y)
Due to and due from
related parties, net
$595K
(8600.00%↑ Y/Y)
Other assets
-$336K
(72.62%↑ Y/Y)
something is missing
-$103,198K
Principal payments on
premium financing
$886K
Net share
settlement for rsus vesting
$319K
(-0.93%↓ Y/Y)
Proceeds from the ripa,
net of issuance...
-$54K
Principal payments of
finance leases
$12K
(200.00%↑ Y/Y)
Net cash used in
investing activities
-$107,469K
(-565.77%↓ Y/Y)
Net cash used in
operating activities
-$66,494K
(16.62%↑ Y/Y)
Canceled cashflow
$60,286K
Canceled cashflow
$178,912K
Effect of exchange rate
changes on cash and cash...
-$3K
(-103.95%↓ Y/Y)
Purchases of marketable
debt securities,...
$164,216K
(990.34%↑ Y/Y)
Net loss
-$230,390K
(-148.87%↓ Y/Y)
Purchases of property,
plant and equipment
$3,516K
(225.25%↑ Y/Y)
Software development
costs
$23K
Accounts receivable
$10,201K
(100.14%↑ Y/Y)
Accretion of discounts on
marketable debt...
$2,272K
(20554.55%↑ Y/Y)
Operating lease
liabilities-Nonrelated Party
-$1,084K
(-9.27%↓ Y/Y)
Operating lease
liabilities-Related Party
-$978K
(-14.79%↓ Y/Y)
Accounts payable
-$247K
(96.03%↑ Y/Y)
Other
-$234K
(-210.90%↓ Y/Y)
Buy us a coffee
Show more